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SUMMARY
Cryptococcus neoformans is an opportunistic fungal pathogen that causes meningoencephalitis as the most frequent clinical
presentation in immunocompromised patients, mainly in people infected by HIV. This fungus is an environmental encapsulated
yeast, commonly found in soil enriched with avian droppings and plant material. A total of 290 samples of pigeon and the other
avian droppings, soil, ornamental trees and vegetable material associated with Eucalyptus trees were collected to study environmental
sources of Cryptococcus species in Goiânia, Goiás State. The determination of varieties, serotypes and the susceptibility in vitro
to fluconazole, itraconazole and amphotericin B of C. neoformans isolates were performed. C. neoformans var. grubii (serotype
A) was found in 20.3% (36/177) of pigeon dropping samples and in 14.3% (5/35) of samples of Eucalyptus. None of the environmental
isolates of C. neoformans showed in vitro resistance to three antifungal agents. The knowledge of major route for human cryptococcal
infection (inhalation of infectious particles from saprophytic sources) and a total of 60 C. neoformans isolates obtained from
AIDS patients with cryptococcal meningitis between October 2001 and April 2002 justify the study of the habitats of these yeasts
as probable sources of cryptococcosis in this city.
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INTRODUCTION
C. neoformans is known as an opportunistic human pathogen that
causes cryptococcosis, a life-threatening illness that usually manifests
as meningoencephalitis mainly in immunocompromised patients6.
This species has five serotypes (A, B, C, D and AD), and recently
was subdivided into three varieties known as C. neoformans var. grubii
(serotype A), C. neoformans var. neoformans (serotype D) and C.
neoformans var. gattii (serotypes B and C)15. Under this classification
the correct designations for serotype AD isolates were not yet resolved22.
C. neoformans serotypes A and D have been isolated from various
sources in nature25. Their association with pigeon’s excreta is known,
but they have also been isolated from droppings of a large variety of
avian species, mainly Psittacidae birds5,13. On the other hand, C.
neoformans var. gattii has been recovered from the environment from
plants detritus of some Eucalyptus species, such as Eucalyptus
camaldulensis and E. tereticornis and from tropical trees hollow21,25.
The treatment regimens for cryptococcal meningitis have remained
focused on amphotericin B with or without fluocytosine for initial or
induction treatment, while azoles (fluconazole or itraconazole) remain
the agent of choice for long-term maintenance therapy, to prevent
recurrences, or as available therapeutic alternative29. Few reports of
resistance to amphotericin B, fluconazole or itraconazole have been
published concerning C. neoformans10,30. However, the widespread use
of fluconazole for long-term suppressive (maintenance) therapy should
be associated with the development of less susceptible strains of this
fungus to this antifungal agent in cryptococcal infections1,4. The
emergence of C. neoformans resistance against commonly used
antifungal agents11 has intensified the need of evaluation of in vitro
susceptibility of this fungus.
The occurrence of cryptococcosis in Goiânia12 and its importance
in immunocompromised patients justify the interest in studying the
environmental sources of Cryptococcus species in this city localized
in the Brazilian midwest region. In this work, we proposed to verify
the presence of these yeasts in urban saprophytic sources and evaluate
the varieties, the serotypes and the in vitro susceptibility of C.
neoformans isolates to fluconazole, itraconazole and amphotericin B.
MATERIAL AND METHODS
Sampling: Samples of pigeon and the avicultures avian droppings,
soil, ornamental trees hollow and samples of barks, leaves, seeds of
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the genus Eucalyptus trees, as well as plants detritus from the ground
were collected in 35 different places in Goiânia, Goiás State, Brazil, at
least twice over a period of one year (2002-2003). The samples were
collected in protected from direct sunlight and unprotected places. The
number and the type of environmental samples collected at different
places are shown in Table 1.
Environmental samples from pigeon and other avian droppings and
from soil were collected with spatulas and placed in identified clean
plastic bags. The samples of trees hollow were collected from discolored
fibrous wood in advanced stages of decay in the inner side of the
hollows. Eucalyptus debris (barks, leaves and seeds) were collected
under the trees canopies by hand and by using spatulas.
Isolation and sample processing: The samples were processed
by according CASALI et al.7 in 48 hours or stored at 4 - 6 ºC until
processing. About 1.0 g of weathered avian droppings and soil or 2.5 g
of material obtained from trees were added to 9.0 mL of sterilized saline
solution 0.9% with both chloramphenicol and ampicillin at 200 mg L-1
each and shaken vigorously for five minutes in Vortex type agitator.
The mixture was left at room temperature for about 10 - 15 minutes.
Next, ten-fold serial dilutions were made and aliquots of
10-1 and 10-2 from the supernatant (birds excretas and soil) or of 10-3
and 10-4 (material of trees) were streaked onto duplicate plates
containing bird seed (Guizotia abyssinica) and Sabouraud dextrose
agar. The cultures were incubated at 32 ºC and at room temperature
for 21 days. Brown yeast-like colonies of suspected C. neoformans,
detected on bird seed agar, were subcultured to obtain single colonies
on Sabouraud dextrose agar plate.
Identification: All environmental isolates were identified by colony
morphology, microscopic morphology of yeast cells and by
carbohydrate assimilation tests. C. neoformans isolates were further
identified on the basis of melanin synthesis on bird seed agar, presence
of a capsule on India ink preparation, urease production on Christensen
medium and the ability to growth at 37 ºC18.
Biotyping and serotyping of C. neoformans: The determination
of C. neoformans variety was performed on canavanine-glicyne-
bromothymol blue (CGB) medium20 and the serotypes were determined
by the slide agglutination test using the Crypto Check Iatron RM 304-
K kit (Iatron Labs., Tokyo, Japan) according to the manufacturers’
instructions.
Antifungal susceptibility testing: Standard broth microdilution
method recomended by the NCCLS M27-A226 was performed to all C.
neoformans isolates. Amphotericin B (Squibb, Princeton, NJ, USA)
and itraconazole (Jansen Pharmaceuticals, Beerse, Belgium) were
dissolved in dimethyl sulfoxide and fluconazole (Pfizer International,
New York, USA) was dissolved in distilled water. Further dilutions of
each antifungal agent were prepared with RPMI 1640 medium (Sigma)
containing L-glutamine, without sodium bicarbonate and buffered to a
pH 7.0 with 0.165M MOPS (morpholinepropanesulfonic acid, Sigma).
The suspension of yeast from 48-h-old cultures was prepared in
sterile saline (0.85%), adjusted with a spectrophotometer to a cell
density of a 0.5 McFarland standard at a wavelength of 530 nm. This
suspension was diluted at 1:50 followed by a 1:20 dilution in RPMI
1640 in order to obtain a final concentration of 1 x 103 to 5 x 103 CFU/
mL. Prior to antifungal susceptibility testing, each isolate was
subcultured at least twice on Sabouraud dextrose agar to ensure purity
and optimal growth.
Microtitre plates were covered with 100 µL of the different
concentrations of the antifungals agents and added with 100 µL of the
yeast suspension to obtain a final inoculum of 0.5 x 103 to 2.5 x 103
CFU/mL and the final concentrations of the antifungal agents ranging
from 0.03 to 64 µg/mL for fluconazole and 0.007 to 16 µg/mL for
itraconazole and amphotericin B. The microdilution trays were
incubated at 35 ºC and read after 72 hours. All susceptibility tests
were performed twice by each antifungal agent. One standard strain,
C. parapsilosis ATCC 22019, was used as internal control in each run
of test26.
Reading results: The MIC end points were defined for
amphotericin B as the lowest concentration of drug which resulted in a
complete inhibition of visible growth. The MICs for the two azoles
were defined as the lowest concentration of drug that produced a
prominent decrease in fungal growth compared to that one of drug-
free growth control.
Interpretation of results: Resistance for C. neoformans
environmental isolates was defined as: MIC ≥ 64 µg/mL for
fluconazole, MIC ≥ 1 µg/mL for itraconazole and MIC ≥ 2 µg/mL for
amphotericin B according to NGUYEN & YU (1998)27 and LOZANO-
CHIU et al. (1998)23.
Table 1
Number of environmental samples collected from several materials at different places in Goiás, Goiânia, Brazil
Places Pigeon droppings Other avian excretas Soil Eucalyptus Ornamental trees Total
Residential buildings (2) 06 - - - - 06
Squares and streets (15) 49 - 04 08 22 83
Hospitals (3) 26 - 08 18 - 52
Churches (6) 92 - - - - 92
Nutritious industry (1) 04 - - - - 04
Avicultures (7) - 44 - - - 44
Police Academy (1) - - - 09 - 09
Total 177 44 12 35 22 290
( ) number of places analyzed
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RESULTS
Out of 290 environmental samples collected, forty-one C.
neoformans isolates were obtained from pigeon droppings and material
associated with eucalyptus trees. No C. neoformans was discovered
from avicultures avian droppings, soil without excretas and ornamental
trees hollow.
All isolates of C. neoformans belonged to C. neoformans var. grubii
(serotype A). C. neoformans var. gattii has not been isolated from any
of the samples examined. C. albidus, C. laurentii and other species of
Cryptococcus were isolated from sites within the urban perimeter,
including the area containing pigeon droppings (Table 2).
Out of the 177 samples of pigeon droppings, collected in 22 places,
C. neoformans var. grubii was recovered from 36 specimens (20.3%)
from five sites (22.7%). These positive sites corresponded to three
churches, one hospital and one nutritious mass industry. C. neoformans
var. grubii was isolated in 35 pigeon dropping samples collected in
nine protected places and in one specimen collected in 13 unprotected
places (Table 3).
C. neoformans var. grubii was recovered only in five barks samples
(14.3%) of the genus Eucalyptus trees collected from one hospital and
from one Police Academy.
None of the environmental isolates of C. neoformans showed in
vitro resistance to three antifungal agents tested. MIC ranges for the
C. neoformans var. grubii isolates were between 0.25 to 2.0 µg/mL
for fluconazole, 0.007 to 0.12 µg/mL for itraconazole and 0.015 to
0.12 µg/mL for amphotericin B. There was no difference between
MIC90 values for itraconazole and amphotericin B (0.12 µg/mL)
while for fluconazole the MIC90 was 1.0 µg/mL. MICs for the quality
control strain were within the expected limits for all antifungal agents
tested.
DISCUSSION
Air transmission route of the desiccated yeast cells or basidiospores
present in the environment which could have the function of C.
neoformans dissemination focus justifies the research of saprophytic
sources of this agent. The positive samples of C. neoformans var. grubii
observed in our study were localized in places close to the great flow
of people, suggesting a high exposure to the fungus. The occasional
exposure to isolates of C. neoformans could be associated with the
infection risk in a given population6. In Goiânia, FERNANDES et al.
(2003)12 related a large number of cases (60 cases) of cryptococcosis
in patients with AIDS during a six months period. The appearance of
C. neoformans serotype A as the most prevalent agent of this disease
in Goiânia, confirms the exposure to environmental sources of this
variety.
Avian droppings have been related as important substrates for the
presence and maintenance of yeast in nature13. The churches studied,
sites where a large amount of pigeon droppings was verified, presented
a heavy contamination by C. neoformans. This contamination was
higher in protected places than in unprotected places. This can be
explained by the high resistance of C. neoformans to desiccation, which
favors the survival of the fungus when competing with other microbial
populations19.
No evidence of isolation of this fungus in avian droppings from
avicultures probably was due to collection of a little weathered samples,
since wet droppings undergo the bacterial decomposition, causing a
strong alkalinization on the substrate and growth inhibition of C.
neoformans19.
Table 3
Distribution of Cryptococcus neoformans var. grubii isolated from pigeon
droppings in different places
Description Place N Samples
n (%)
Churches P 82 34 (41.5)
UP 10 - -
Hospital P - - -
UP 26 01 (3.8)
Squares and streets P 08 - -
UP 41 - -
Nutritious industry P 04 01 (25)
UP - - -
Residential buildings P 06 - -
UP - - -
Total P 100 35 (35.0)
UP 77 01 (1.3)
P = protected place; UP = unprotected place; N = total number; n = number of
positive samples.
Table 2
Cryptococcus species other than neoformans isolated from 290 environmental samples collected in the urban environment of Goiânia, Goiás, Brazil
Cryptococcus Places
species Residential building Square and street Hospital Church Nutritious industry Aviary Police Academy Total
C. albidus 01 07 09 39 04 02 - 62
C. laurentii - 03 02 05 01 - - 11
C. uniguttulatus - - 01 07 - 02 - 10
C. luteolus - - 02 01 - - - 03
C. gastricus - - 01 - 01 01 - 03
C. terreus - - 01 - - - - 01
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With respect to the other samples collected, the absence of positivity
of the C. neoformans could have occurred because of the overgrowth
of fast-growing filamentous fungi. This possibly led to false-negative
results in the bird seed agar plating method14.
In spite of a high correlation of C. neoformans var. gattii with
eucalyptus, we have not found this variety. In Brazil, MONTENEGRO
& PAULA (2000)25 have recovered C. neoformans var. gattii from
Eucalyptus spp trees vegetable material in São Paulo. This variety was
also detected in Teresina, Brazil, in eucalyptus samples, but its isolation
happened after inoculation in mice3. The biologic competition among
microorganisms in wood decomposition process explains the difficulty
to isolate these fungi16. Therefore, furthermore extensive studies are
needed to confirm the presence or absence of C. neoformans var. gattii
from environmental sources in Goiânia.
The presence of C. albidus, C. laurentii and C. uniguttulatus
recovered in the environment is an important data. These species have
been reported as agents of opportunistic infection such as meningitis,
lung infections, fungaemia, abscess and skin infection, mainly in
patients with great deterioration of the immune response8,17.
The low MICs values of C. neoformans environmental isolates
presented to fluconazole, amphotericin B and itraconazole are consistent
with the current literature on which the majority of the C. neoformans
isolates are in vitro susceptible to these three antifungal1,9. However,
low sensivity of environmental isolates to fluconazole has been
demonstrated. BARONI (2001)2, using the Etest methodology, verified
the resistance to this antifungal agent for 75.86% of C. neoformans
isolates obtained from pigeon droppings in Rio de Janeiro.
Resistance of C. neoformans clinical isolates to fluconazole has
been related in AIDS patients and in immunocompetent patient10,24.
The isolate resistance to this antifungal agent can occur due to a previous
or extended maintenance treatment, or prophylaxis in
immunocompromised patients30. However, fluconazole-resistant C.
neoformans isolates obtained from immunocompetent patient without
exposure to this azole suggest that environmental strains can be
primarily resistant to this antifungal agent28.
The present study showed the presence of C. neoformans in urban
environmental sources at places of high public circulation in Goiânia.
Since the exposure to dry inhalable spores from these reservoirs seems
to be linked to cryptococcal infection and due to the
immunocompromised individuals are considered the patients at risk
for cryptococcosis, the elucidation of the ecology of this yeast has
been very important.
RESUMO
Caracterização de Cryptococcus neoformans isolados de fontes
ambientais urbanas na cidade de Goiânia, estado de Goiás,
Brasil
Cryptococcus neoformans é um fungo patogênico oportunista que
causa meningoencefalite como a apresentação clínica mais importante
em pacientes imunocomprometidos, principalmente, em pessoas
infectadas pelo HIV. O agente é uma levedura encapsulada, comumente
encontrada em solo enriquecido com excretas de aves e em resíduos
de plantas. O total de 290 amostras de excretas de pombos e outras
aves, de árvores ornamentais e materiais vegetais de Eucalyptus foram
coletadas para estudar possíveis fontes ambientais de Cryptococcus
spp, na cidade de Goiânia, Goiás. A determinação das variedades,
sorotipos e suscetibilidade in vitro frente a fluconazol, itraconazol e
anfotericina B dos isolados de C. neoformans foram realizadas. C.
neoformans var. grubii (sorotipo A) foi a única isolada, ocorrendo em
36 (20.3%) das 177 amostras fecais de pombos e em 5 (14.3%) das 35
amostras de Eucalyptus. Nenhum dos isolados ambientais de C.
neoformans mostrou resistência in vitro aos três antifúngicos avaliados.
O conhecimento da principal via para infecção criptocócica humana,
isto é inalação de partículas infecciosas de fontes saprofíticas e a
ocorrência de 60 casos de criptococose em pacientes com AIDS, em
Goiânia, entre outubro de 2001 e abril de 2002, justificam o estudo de
habitats do agente como prováveis fontes de criptococose nesta cidade.
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